W
Wangyang You
Researcher at Centers for Disease Control and Prevention
Publications - 10
Citations - 2185
Wangyang You is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 4, co-authored 5 publications receiving 814 citations. Previous affiliations of Wangyang You include Chinese Center for Disease Control and Prevention.
Papers
More filters
Journal ArticleDOI
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial.
Shengli Xia,Yuntao Zhang,Y. Wang,Hui Wang,Yunkai Yang,George F. Gao,Wenjie Tan,Guizhen Wu,Miao Xu,Zhiyong Lou,Weijin Huang,Wenbo Xu,Baoying Huang,Huijuan Wang,Wei Wang,Wei Zhang,Na Li,Zhiqiang Xie,Ling Ding,Wangyang You,Yuxiu Zhao,Xuqin Yang,Yang Liu,Qian Wang,Lili Huang,Yongli Yang,Guangxue Xu,Bojian Luo,Wenling Wang,Peipei Liu,Wanshen Guo,Xiaoming Yang +31 more
TL;DR: The primary outcomes were safety and tolerability and immunogenicity, assessed as the neutralising antibody responses against infectious SARS-CoV-2, and no serious adverse event was reported within 28 days post vaccination.
Journal ArticleDOI
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.
Shengli Xia,Kai Duan,Yuntao Zhang,Dongyang Zhao,Huajun Zhang,Zhiqiang Xie,Xinguo Li,Cheng Peng,Yan-Bo Zhang,Wei Zhang,Yunkai Yang,Wei Chen,Xiaoxiao Gao,Wangyang You,Xue-Wei Wang,Zejun Wang,Zhengli Shi,Y. Wang,Xuqin Yang,Lianghao Zhang,Lili Huang,Qian Wang,Jia Lu,Yongli Yang,Jing Guo,Wei Zhou,Xin Wan,Cong Wu,Wenhui Wang,Shihe Huang,Du Jianhui,Ziyan Meng,An Pan,Zhiming Yuan,Shuo Shen,Wanshen Guo,Xiaoming Yang +36 more
TL;DR: In this interim report of the phase 1 and phase 2 trials of an inactivated COVID-19 vaccine, patients had a low rate of adverse reactions and demonstrated immunogenicity; the study is ongoing.
Journal ArticleDOI
Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial.
Nawal Al Kaabi,Yuntao Zhang,Shengli Xia,Yunkai Yang,Manaf M Al Qahtani,Najiba Abdulrazzaq,Majed Al Nusair,Mohamed Hassany,Jaleela S Jawad,Jehad Abdalla,Salah Eldin Hussein,Shamma K Al Mazrouei,Maysoon Al Karam,Xinguo Li,Xuqin Yang,Wei Wang,Bonan Lai,Wei Chen,Shihe Huang,Qian Wang,Tian Yang,Liu Yang,Rui Ma,Zaidoon M Hussain,Tehmina Khan,Mohammed Saifuddin Fasihuddin,Wangyang You,Zhiqiang Xie,Yuxiu Zhao,Zhiwei Jiang,Guoqing Zhao,Yan-Bo Zhang,Sally Mahmoud,Islam Eltantawy,Peng Xiao,Ashish Koshy,Walid Abbas Zaher,Hui Wang,Kai Duan,An Pan,Xiaoming Yang +40 more
TL;DR: In this paper, the efficacy and adverse events of 2 inactivated COVID-19 vaccines were evaluated in a randomized, double-blind, phase 3 trial in the United Arab Emirates and Bahrain among adults 18 years and older.
Journal ArticleDOI
Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial.
Shengli Xia,Isakova A'lo Anvarjonovna,Yuntao Zhang,Y. Wang,Hui Wang,Yunkai Yang,George F. Gao,Wenjie Tan,Guizhen Wu,Miao Xu,Zhiyong Lou,Weijin Huang,Wenbo Xu,Baoying Huang,Wei Wang,Wei Zhang,Na Li,Zhiqiang Xie,Xiujuan Zhu,Ling Ding,Wangyang You,Yuxiu Zhao,Jun Zhao,Lili Huang,Xuezhong Shi,Yongli Yang,Guangxue Xu,Wenling Wang,Peipei Liu,Meng Ma,YuLing Qiao,SuHua Zhao,JingJing Chai,Qinqin Li,Hui Fu,Ying Xu,XiaoTong Zheng,Wanshen Guo,Xiaoming Yang +38 more
TL;DR: Wang et al. as mentioned in this paper assessed the safety and immunogenicity of BBIBP-CorV in participants aged 3-17 years, using a randomized, double-blind, controlled, phase 1/2 trial at Shangqiu City Liangyuan District Center for Disease Control and Prevention in Henan, China.
Journal ArticleDOI
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial
Wanshen Guo,Kai Duan,Yuntao Zhang,Zhiming Yuan,Yan-Bo Zhang,Zejun Wang,Dongyang Zhao,Huajun Zhang,Zhiqiang Xie,Xinguo Li,Cheng Peng,Wei Zhang,Yunkai Yang,Wei Chen,Xiaoxiao Gao,Wangyang You,Xue-Wei Wang,Zhengli Shi,Y. Wang,Xuqin Yang,Lianghao Zhang,Lili Huang,Qian Wang,Jia Lu,Yongli Yang,Jing Guo,Wei Zhou,Xin Wan,Cong Wu,Wenhui Wang,Du Jianhui,Xuanxuan Nian,Xing-Hang Li,Shihe Huang,Shuo Shen,Shengli Xia,An Pan,Xiaoming Yang +37 more
TL;DR: Wang et al. as mentioned in this paper assessed the safety and immunogenicity of an inactivated vaccine against COVID-19 in Chinese adults aged ≥18 years. But they did not report any detectable antibody responses in all the groups.